Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphomaJonathan H. Schatz, Hans‐Guido Wendel|The Journal of Experimental Medicine|2011Cited by 114
Frequent disruption of the RB pathway in indolent follicular lymphoma suggests a new combination therapyElisa Oricchio, Hans‐Guido Wendel|The Journal of Experimental Medicine|2014Cited by 33
Noncovalent inhibitors reveal BTK gatekeeper and auto-inhibitory residues that control its transforming activityShenqiu Wang, Hans‐Guido Wendel|JCI Insight|2019Cited by 33
Ectopic activation of the miR-200c–EpCAM axis enhances antitumor T cell responses in models of adoptive cell therapyMinggang Zhang, Morgan Huse, Andrew Scott et al.|Science Translational Medicine|2021Cited by 13
A Rapid Translational Immune Response Program in CD8 Memory T LymphocytesDarin Salloum, Hans‐Guido Wendel|The Journal of Immunology|2022Cited by 12